From Narrative to Story: How We Do Public Relations
Two members of CG Life's Public Relations department walk us through and discuss four main components to the public relations process.
Transforming Patient Care in the New Age of Gene Therapy
Standing at the cusp of such an exciting and impactful moment in medicine, we are now more certain than ever that gene therapies can provide life-changing benefits to many. Looking
Magnify Your Marketing and Public Relations with a Strategic Editorial Calendar
The media landscape is extremely noisy, yet your job is to figure out how to generate visibility for your organization. So, how do you set your company up for maximum media coverag
How to Restore Trust in Science and Address Public Fear of the Unknown
The growing role of science and technology in public life has created a scenario where the scientific and medical communities can not afford to ignore public distrust. This post ex
CG Life Media Survey: Public Relations During a Pandemic
The CG Life PR team polled their media network to better understand the changing work environment of journalism. Within, find some of the key learnings from our survey results.
UNWIND 2019: CG Life Hosts Chicago’s Most Relaxed Networking Event for Life Science Professionals
On June 13, over 160 professionals from all sectors of the life science community joined CG Life at our warehouse-turned-office, event space and music lounge for Chicago’s most r
The Medical Benefits of CBD: Real, or Just Hype?
There’s a health food store in my neighborhood that’s been there for ages, and I never looked twice at it until the other week when I saw a poster on their window proudly promo
23andMe Sold Your Genetic Data to GSK: What this Means for You, Your Data, and Your Health
Earlier this summer, the often-scrutinized at-home genetic testing company 23andMe sold genetic data from five million customers to the pharmaceutical company GlaxoSmithKline (GSK)
How To Write to Experts…About Something They’re Not An Expert In
If you are working in marketing for a life science or healthcare company, chances are, you are writing to a pretty intelligent audience. You may be writing to business executives,
Avoiding a PR Nightmare: How Spark Therapeutics Overcame a Potential Crisis in the Launch of Their First Gene Therapy
On December 19, 2017, the FDA approved a novel gene therapy that treats diseases that affect vision. Luxturna™, from Spark Therapeutics, treats a number of retinal diseases cause